Blog | Veristat Insightful Perspectives

Selecting the Right EDC System for a Clinical Program

Understanding the Various Considerations for EDC Selection

 


Read More

Key Strategies for Overcoming Data Analysis Difficulties During NDA/MAA Submissions


When database locks are delayed, or regulatory agencies request additional analyses for new drug applications (NDAs) or marketing authorization applications (MAAs), it seems there is no alternative but to take a hit to the timeline — or is there?

Read More

Flexibility is the Key to Data Acquisition for Rare Disease Trials

Understanding Why Creative Data Collection Solutions Are Necessary

Read More